• Optimi Health Corp.(OPTI) has appointed Dr. Azim Jamal to its Advisory Board, and Leah Hodges to the role of Corporate Secretary
  • Dr. Jamal is a respected industry leader who has extensive experience overseeing a diverse portfolio of business investments
  • Dr. Jamal is a recipient of the Ernst & Young Entrepreneur of the Year Award and winner of the Business in Vancouver Top 40 Under 40 Outstanding Achievement Award
  • With 13 years of experience, Mrs. Hodges specializes in corporate, commercial and securities compliance, corporate governance, mergers and acquisitions
  • Optimi Health has finalized an agreement to add fitness and nutrition specialist Harley Pasternak to its growing Advisory Board
  • Optimi Health Corp. is developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness food markets
  • Optimi Health Corp.(OPTI) is up 4 per cent, trading at C$0.78 per share at 1:30 pm ET

Optimi Health Corp.(OPTI) has appointed Dr. Azim Jamal to its Advisory Board, and Leah Hodges to the role of Corporate Secretary.

Dr. Jamal is the CEO and Co-Founder of Pacific Reach, established in 2014, and is responsible for leading all business activities for that company.

He is a respected industry leader who has extensive experience overseeing a diverse portfolio of business investments including hotels, commercial properties, and seniors care communities. For over 20 years, Dr. Jamal was the President and Chief Executive Officer of Retirement Concepts. 

Dr. Jamal is a former family physician. After practicing as a family physician in Greater Vancouver, Dr. Jamal went on to found Dermal Laser Centers – a chain of medical aesthetic clinics which he subsequently sold. He is a member of the Young Presidents’ Organization in Vancouver, B.C., a recipient of the Ernst & Young Entrepreneur of the Year Award and a winner of the Business in Vancouver Top 40 Under 40 Outstanding Achievement Award.

Appointed as Corporate Secretary, Mrs. Hodges is the principal of Benchmark Governance, providing corporate compliance, administration, and governance support to private and public companies in the resource, industrial and technology sectors.

Mrs. Hodges specializes in corporate, commercial and securities compliance, corporate governance, mergers and acquisitions. Mrs. Hodges is a Commissioner for Taking Affidavits in British Columbia, has an Associate of Arts degree from Capilano University, and is a member of the Governance Professionals of Canada and Institute of Corporate Directors.

Optimi Health’s CEO, Mike Stier notes,

“The need for governance is a fundamental aspect of any business and the addition of Benchmark will support our team in this area. We are grateful to have attracted the interest and participation of a growing number of highly experienced business people who bring a diverse collection of interest, expertise and accomplishments to our team.

We welcome Azim and Leah and look forward to working together to help grow Optimi into a sector-leading and valued opportunity for our stakeholders and investors alike.”

Optimi Health has finalized an agreement to add globally-recognized fitness and nutrition specialist Harley Pasternak to its growing Advisory Board.

Optimi Health Corp. is developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness food markets.

The company also intends to cultivate, extract, process and distribute high-quality strains of fungi products at its GMP-certified facility located in Princeton, British Columbia.

Optimi Health Corp.(OPTI) is up 4 per cent, trading at C$0.78 per share at 1:30 pm ET.

More From The Market Online

Psychedelic stock begins take-home LSD microdosing clinical trial

MindBio Therapeutics (CSE:MBIO) secures approvals for MB22001 – a form of LSD – microdosing use by patients in a controlled clinical trial.

Red Light Holland begins experimental research on psilocybin truffles

Red Light Holland has revealed that it has officially begun an experimental research project on its psilocybin truffles.
MindBio Therapeutics chief executive officer Justin Hanka.

Psychedelic stock clears hurdle to treating depression with LSD

Psychedelic stock MindBio (CSE:MBIO) is revealing positive top-line data from its pioneering microdosing clinical trial to treat depression.

Clearmind Medicine to begin alcohol use disorder clinical trial

Clearmind Medicine (CSE:CMND) has received approval to begin its phase I/IIa clinical trial for alcohol use disorder in Israel.